Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells

Clinical Cancer Research

Volumn 5, Issue 7, 1999, Pages 1876-1883

  Motwani, Monica ^a   Delohery, Thomas M ^b   Schwartz, Gary K ^a,b  

^a Division of Solid Tumor Oncology   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; FLAVOPIRIDOL; PACLITAXEL; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CASPASES; CDC2 PROTEIN KINASE; CYCLIN B; DRUG INTERACTIONS; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; MITOSIS; PACLITAXEL; PIPERIDINES; POLY ADENOSINE DIPHOSPHATE RIBOSE; RETINOBLASTOMA PROTEIN; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032804733     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sarosy, G., and Reed, E. Taxol dose intensification and its clinical implications. J. Natl. Med. Assoc., 85: 427-431, 1993.
2. Rowinsky, E. K., and Donehower, R. C. Paclitaxel (Taxol). N. Engl. J. Med., 332: 1004-1014, 1995.
3. Senderowicz, A. M., Headlee, D., Stinson, S. F., Lush, R. M., Kalil, N., Villalba, L., Hill, K., Steinberg, S. M., Figg, W. D., Tompkins, A., Arbuck, S. G., and Sausville E. A. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms. J. Clin. Oncol., 16: 2986-2999, 1998.
4. Kaur, G., Stetler-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R., and Sausville, E. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J. Natl. Cancer Inst., 84: 1736-1740, 1992.
5. Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., and Worland, P. J. Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun., 201: 589-595, 1994.
6. 1 arrest with inhibition of cyclin-dependent kinase CDK 2 and CDK4 in human breast carcinoma cells. Cancer Res., 56: 2973-2978, 1996.
7. Schwartz, G. K., Farsi, K., Maslak, P., Kelsen, D. P., and Spriggs, D. Potentiation of apoptosis by flavopiridol in mitomycin C-treated gastric and breast cancer cells. Clin. Cancer Res., 3: 1467-1472, 1997.
8. Werner, J. L., Greaney, C., Spriggs, D., Kelsen, D. K., and Schwartz, G. K. The enhancement of chemotherapy-induced apoptosis by flavopiridol in gastric cancer cells is sequence dependent. Proc. Am. Soc. Clin. Oncol., 16: 547a, 1997.
9. Bible, K. C., Kaufmann, S. H. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration. Cancer Res., 57: 3375-3380, 1997.
10. Schiff, P. B., Fant, J., and Horwitz, S. B. Promotion of microtubule assembly in vitro by Taxol. Nature (Lond.), 277: 665-667, 1979.
11. cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Differ., 9: 23-29, 1998.
12. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. Human ICE/CED-3 protease nomenclature. Cell, 87: 171, 1996.
13. Salvesen, G. S., and Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell, 91: 443-446, 1997.
14. Lazebnik, Y. A., Takahashi, A., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., and Earnshaw, W. C. Studies of the lamin protease reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA, 92: 9042-9046, 1995.
15. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs. Cancer Res., 49: 5870-5878, 1989.
16. Voelkek-Johnson, C., Entingh, A. J., Wold, W. S. M., Gooding, L. R., and Laster, S. M. Activation of intracellular protease is an early event in TNF-induced apoptosis. J. Immunol., 154: 1707-1716, 1995.
17. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
18. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., Poirier, G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
19. Panvichian, R., Orth, K., Day, M., Day, K. C., Pilat, M. J., and Pienta, K. J. Paclitaxel-associated multimininucleation is permitted by the inhibition of caspase activation: a potential early step in drug resistance. Cancer Res., 58: 4667-4672, 1998.
20. L overexpression inhibits Taxol-induced Yama protease activity and apoptosis. Cell Growth Differ., 7: 1087-1094, 1996.
21. Vandre, D. D., and Borisy, G. G. Anaphase onset and dephosphorylation of mitotic phosphoproteins occur concomitantly. J. Cell Sci., 94: 245-258, 1989.
22. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., and Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med., 95: 506-526, 1995.
23. Murray, A. W., Solomon, M. J., and Kirchner, M. W. The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature (Lond.), 339: 280-286, 1989.
24. Lorca, T. C., Labbe, J. C., Devault, A., Fesquet, D., Capony, J. P., Cavadore, J. C., Le Bouffant, F., and Doree, M. Dephosphorylation of cdc-2 on thr 161 is required for cdc-2 kinase inactivation and normal anaphase. EMBO J., 11: 2381-2390, 1992.
25. Poon, R. Y. C., Chau, M. S., Yarnashita, K., and Hunter, T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res., 57: 5168-5178, 1997.
26. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentration of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
27. Donaldson, K. L., Goolsby, G. L., and Wahl, A. F. Cytotoxicity of the anticancer agents cisplatin and Taxol during cell proliferation and the cell cycle. Int. J. Cancer, 57: 847-855, 1994.